Stocktoria
CG Oncology, Inc. CGON
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-01-25
CG Oncology, Inc. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 1,976,070 | $62.4M | 2.45% |
| Point72 Asset Management, L.P. | 425,292 | $28.8M | 0.53% |
| CITADEL ADVISORS LLC | 267,815 | $18.1M | 0.33% |
| AQR CAPITAL MANAGEMENT LLC | 114,342 | $7.7M | 0.14% |
| D. E. Shaw & Co., Inc. | 46,610 | $3.2M | 0.06% |
| MILLENNIUM MANAGEMENT LLC | 20,000 | $1.4M | 0.02% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.